GlobeNewswire Inc.··Hagens BermanSoleno Therapeutics Faces Securities Class Action Over VYKAT XR Safety Disclosures
Hagens Berman files securities class action against $SLNO alleging concealed safety risks and inflated metrics for hyperphagia drug VYKAT XR. Stock crashed 27% following August activist report and November earnings miss.
SLNOinvestor lossessecurities class action